Number of the records: 1  

hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges

  1. 1.
    0478710 - ÚEM 2018 RIV US eng J - Journal Article
    Lukovic, D. - Moreno-Manzano, V. - Rodriquez - Jimenez, F.J. - Vilches, A. - Syková, Eva - Jendelová, Pavla - Stojkovic, M. - Erceg, Slaven
    hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges.
    Neuroscientist. Roč. 23, č. 5 (2017), s. 554-566. ISSN 1073-8584. E-ISSN 1089-4098
    R&D Projects: GA ČR(CZ) GBP304/12/G069; GA MŠMT(CZ) LO1309; GA MŠMT(CZ) ED1.1.00/02.0109
    Institutional support: RVO:68378041
    Keywords : 3D organoids * ataxia * disease modelling
    OECD category: Developmental biology
    Impact factor: 7.461, year: 2017

    Cerebellar ataxias are clinically and genetically heterogeneous diseases affecting primary cerebellar cells. The lack of availability of affected tissue from cerebellar ataxias patients is the main obstacle in investigating the pathogenicity of these diseases. The landmark discovery of human-induced pluripotent stem cells (hiPSC) has permitted the derivation of patient-specific cells with an unlimited self-renewing capacity. Additionally, their potential to differentiate into virtually any cell type of the human organism allows for large amounts of affected cells to be generated in culture, converting this hiPSC technology into a revolutionary tool in the study of the mechanisms of disease, drug discovery, and gene correction. In this review, we will summarize the current studies in which hiPSC were utilized to study cerebellar ataxias. Describing the currently available 2D and 3D hiPSC-based cellular models, and due to the fact that extracerebellar cells were used to model these diseases, we will discuss whether or not they represent a faithful cellular model and whether they have contributed to a better understanding of disease mechanisms.
    Permanent Link: http://hdl.handle.net/11104/0275496

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.